Phase 0 2 trials
Phase 0
NCT06366451 May 2024 → Mar 2026 head and neck squamous cell carcinoma Presage Biosciences
Completed
No outcome recorded
Phase 0
NCT04541108 Jul 2021 → Dec 2031 expected cancer Presage Biosciences
Active not recruiting
No outcome recorded
Phase 1 4 trials
Phase 1
NCT07161414 Nov 2025 → Jul 2027 expected cancer AstraZeneca
Recruiting
No outcome recorded
Phase 1
NCT04686305 Mar 2021 → Jun 2027 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 1
NCT04612751 Feb 2021 → May 2026 overdue non-small cell lung carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 1
NCT03819465 Dec 2018 → May 2023 overdue non-small cell lung carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 1/2 4 trials
Phase 1/2
NCT06996782 Nov 2025 → Feb 2029 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 1/2
NCT07115043 Jul 2025 → Oct 2029 expected cutaneous neuroendocrine carcinoma , gastroesophageal cancer , head and neck squamous cell carcinoma , melanoma +5 AstraZeneca
Recruiting
No outcome recorded
Phase 1/2
NCT05123482 Oct 2021 → Sep 2027 expected biliary tract cancer , breast carcinoma , endometrial cancer , non-small cell squamous lung carcinoma +1 AstraZeneca
Recruiting
No outcome recorded
Phase 1/2
NCT04995523 Sep 2021 → Aug 2026 overdue non-small cell lung carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 2 11 trials
Phase 2
NCT07128290 Oct 2025 → Apr 2029 expected intrahepatic cholangiocarcinoma Federation Francophone de Cancerologie Digestive
Not yet recruiting
No outcome recorded
Phase 2
NCT07098338 Aug 2025 → Apr 2029 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 2
NCT07069712 Jul 2025 → Jan 2027 expected gastroesophageal adenocarcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 2
NCT06630130 Jan 2025 → Oct 2028 expected gastric cancer Jeeyun Lee
Recruiting
No outcome recorded
Phase 2
NCT06569225 Dec 2024 → Dec 2027 expected cholangiocarcinoma University Health Network, Toronto
Not yet recruiting
No outcome recorded
Phase 2
NCT05414032 Jul 2023 → Sep 2027 expected head and neck squamous cell carcinoma University Health Network, Toronto
Recruiting
No outcome recorded
Phase 2
NCT05775159 Apr 2023 → Oct 2026 expected biliary tract cancer , hepatocellular carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 2
NCT05702229 Jan 2023 → Nov 2027 expected gastric cancer AstraZeneca
Recruiting
No outcome recorded
Phase 2
NCT05061550 Apr 2022 → May 2030 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 2
NCT04379596 Jun 2020 → Jun 2027 expected gastric cancer AstraZeneca
Recruiting
No outcome recorded
Phase 2
NCT01042379 Mar 2010 → Dec 2030 expected HER2 positive breast carcinoma , angiosarcoma , female breast carcinoma , hormone receptor-positive breast cancer +1 QuantumLeap Healthcare Collaborative
Recruiting
No outcome recorded
Show 1 more trial Phase 3 12 trials
Phase 3
NCT07431281 Feb 2026 → Aug 2029 expected esophageal cancer , gastric cancer , gastroesophageal junction adenocarcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT07221253 Dec 2025 → Jul 2029 expected biliary tract cancer AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06921785 May 2025 → Mar 2029 expected hepatocellular carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06868277 Apr 2025 → Jan 2030 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06989112 Mar 2025 → Jan 2029 expected endometrial cancer AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06764875 Mar 2025 → Apr 2029 expected gastroesophageal junction adenocarcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06627647 Nov 2024 → Nov 2030 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06692738 Nov 2024 → Jul 2030 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06564844 Oct 2024 → Jun 2027 expected non-small cell lung carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 3
NCT06467357 Aug 2024 → Jun 2028 expected biliary tract cancer AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06357533 Apr 2024 → Dec 2029 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06109779 Dec 2023 → Jan 2029 expected biliary tract cancer AstraZeneca
Active not recruiting
No outcome recorded
Show 2 more trials